Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No.1, Minde Road, 330006, Nanchang, Jiangxi, China.
Jiangxi Key Laboratory of Molecular Medicine, Nanchang, Jiangxi, China.
Cardiovasc Diabetol. 2023 Jun 12;22(1):134. doi: 10.1186/s12933-023-01861-0.
Abnormal glycemic variability is common in the intensive care unit (ICU) and is associated with increased in-hospital mortality and major adverse cardiovascular events, but little is known about whether adverse outcomes are partly mediated by ventricular arrhythmias (VA). We aimed to explore the association between glycemic variability and VA in the ICU and whether VA related to glycemic variability mediate the increased risk of in-hospital death.
We extracted all measurements of blood glucose during the ICU stay from The Medical Information Mart for Intensive Care IV (MIMIC-IV) database version 2.0. Glycemic variability was expressed by the coefficient of variation (CV), which was calculated by the ratio of standard deviation (SD) and average blood glucose values. The outcomes included the incidence of VA and in-hospital death. The KHB (Karlson, KB & Holm, A) is a method to analyze the mediation effect for nonlinear models, which was used to decompose the total effect of glycemic variability on in-hospital death into a direct and VA-mediated indirect effect.
Finally, 17,756 ICU patients with a median age of 64 years were enrolled; 47.2% of them were male, 64.0% were white, and 17.8% were admitted to the cardiac ICU. The total incidence of VA and in-hospital death were 10.6% and 12.8%, respectively. In the adjusted logistic model, each unit increase in log-transformed CV was associated with a 21% increased risk of VA (OR 1.21, 95% CI: 1.11-1.31) and a 30% increased risk (OR 1.30, 95% CI: 1.20-1.41) of in-hospital death. A total of 3.85% of the effect of glycemic variability on in-hospital death was related to the increased risk of VA.
High glycemic variability was an independent risk factor for in-hospital death in ICU patients, and the effect was caused in part by an increased risk of VA.
血糖变异性异常在重症监护病房(ICU)中很常见,并且与住院期间死亡率和主要不良心血管事件的增加有关,但尚不清楚不良结局是否部分由室性心律失常(VA)介导。我们旨在探讨 ICU 中血糖变异性与 VA 之间的关系,以及与血糖变异性相关的 VA 是否介导住院期间死亡风险的增加。
我们从 ICU 住院期间的 The Medical Information Mart for Intensive Care IV(MIMIC-IV)数据库版本 2.0 中提取了所有血糖测量值。血糖变异性用变异系数(CV)表示,通过标准差(SD)与平均血糖值的比值计算得出。结果包括 VA 的发生率和住院期间的死亡率。KHB(Karlson、KB 和 Holm,A)是一种用于分析非线性模型中介效应的方法,用于将血糖变异性对住院期间死亡率的总效应分解为直接效应和 VA 介导的间接效应。
最终纳入了 17756 名 ICU 患者,中位年龄为 64 岁;其中 47.2%为男性,64.0%为白人,17.8%入住心脏 ICU。VA 和住院期间死亡率的总发生率分别为 10.6%和 12.8%。在调整后的逻辑模型中,log 变换后的 CV 每增加一个单位,VA 的风险增加 21%(OR 1.21,95%CI:1.11-1.31),住院期间死亡率的风险增加 30%(OR 1.30,95%CI:1.20-1.41)。血糖变异性对住院期间死亡率的影响中,有 3.85%与 VA 风险增加有关。
高血糖变异性是 ICU 患者住院期间死亡的独立危险因素,其作用部分是由 VA 风险增加引起的。